Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05483088 · ClinicalTrials.gov registry record

Urine Sample Processing Study

A clinical trial, sponsored by Astute Medical.

Completed
Registry status
110
Enrollment target

NCT05483088: Completed study, sponsored by Astute Medical.

NCT05483088 is a clinical trial that has completed, run by Astute Medical. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05483088 has completed, sponsored by Astute Medical.

COMPLETED
Registry status
110 participants
Enrollment target

Study Summary

The objective of the study is to collect and process urine samples from Intensive Care Unit (ICU) subjects with moderate to severe (Stage 2 or 3) acute kidney injury (AKI) for use in assessing the effects of urine sample freezing and various storage conditions on NEPHROCLEAR™ CCL14 Test results. This study is observational and will have no impact on the medical management of the subject.

Primary Outcome

Stability of CCL14 in urine samples as measured by the NEPHROCLEAR™ CCL14 Test

Interventions

  • DIAGNOSTIC_TEST Urine collection for NEPHROCLEAR CCL14 Test

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2021-11-12
Est. Completion 2023-07-31
Astute Medical

6 total trials

What the finished NCT05483088 record still lists

NCT05483088 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Urine collection for NEPHROCLEAR CCL14 Test is the first listed.

NCT05483088 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05483088 about?

NCT05483088 is a clinical study titled "Urine Sample Processing Study". The objective of the study is to collect and process urine samples from Intensive Care Unit (ICU) subjects with moderate to severe (Stage 2 or 3) acute kidney injury (AKI) for use in assessing the effects of urine sample freezing and various storage conditions on NEPHROCLEAR™ CCL14 Test results. Thi...

What is the current status of trial NCT05483088?

This trial is currently completed. The enrollment target is 110 participants. The study started on 2021-11-12. Estimated completion is 2023-07-31.

What interventions are being tested in trial NCT05483088?

The interventions under investigation include: Urine collection for NEPHROCLEAR CCL14 Test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05483088?

This trial is sponsored by Astute Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05483088, the US trial registry maintained by the National Library of Medicine. NCT05483088 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.